Evolent Health Stock Price To Earnings To Growth
| 9EH Stock | EUR 10.70 0.40 3.88% |
Evolent Health fundamentals help investors to digest information that contributes to Evolent Health's financial success or failures. It also enables traders to predict the movement of Evolent Stock. The fundamental analysis module provides a way to measure Evolent Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evolent Health stock.
Evolent |
Evolent Health Company Price To Earnings To Growth Analysis
Evolent Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Evolent Health has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Technology sector and 100.0% lower than that of the Health Information Services industry. The price to earnings to growth for all Germany stocks is 100.0% higher than that of the company.
Evolent Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evolent Health's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Evolent Health could also be used in its relative valuation, which is a method of valuing Evolent Health by comparing valuation metrics of similar companies.Evolent Health is currently under evaluation in price to earnings to growth category among its peers.
Evolent Fundamentals
| Return On Equity | -0.0241 | |||
| Return On Asset | 0.002 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 3.01 B | |||
| Shares Outstanding | 111.05 M | |||
| Shares Owned By Insiders | 14.57 % | |||
| Shares Owned By Institutions | 92.75 % | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 2.16 X | |||
| Revenue | 1.35 B | |||
| Gross Profit | 316.58 M | |||
| EBITDA | 20.69 M | |||
| Net Income | (19.16 M) | |||
| Cash And Equivalents | 172.86 M | |||
| Cash Per Share | 2.11 X | |||
| Total Debt | 215.68 M | |||
| Debt To Equity | 24.60 % | |||
| Current Ratio | 1.96 X | |||
| Book Value Per Share | 8.60 X | |||
| Cash Flow From Operations | (11.55 M) | |||
| Earnings Per Share | (0.19) X | |||
| Target Price | 28.33 | |||
| Number Of Employees | 4 K | |||
| Beta | 1.56 | |||
| Market Capitalization | 3.69 B | |||
| Total Asset | 1.82 B | |||
| Z Score | 10.2 | |||
| Net Asset | 1.82 B |
About Evolent Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evolent Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evolent Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evolent Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Evolent Stock
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.